Insider Transactions in Q1 2023 at Incyte Corp (INCY)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
318
+2.64%
|
$22,896
$72.27 P/Share
|
|
Mar 31
2023
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
326
+3.5%
|
$23,472
$72.27 P/Share
|
|
Mar 31
2023
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
858
+0.01%
|
-
|
|
Mar 13
2023
|
Baker Bros. Advisors LP |
BUY
Exercise of conversion of derivative security
|
Indirect |
40,000
+0.36%
|
$880,000
$22.74 P/Share
|
|
Feb 16
2023
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,693
+6.09%
|
$240,045
$65.42 P/Share
|
|
Feb 13
2023
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,179
-0.76%
|
$94,320
$80.08 P/Share
|
|
Jan 31
2023
|
Maria E Pasquale EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
802
-1.16%
|
$67,368
$84.06 P/Share
|
|
Jan 31
2023
|
Maria E Pasquale EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
802
+1.14%
|
$59,348
$74.78 P/Share
|
|
Jan 30
2023
|
Maria E Pasquale EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
60,024
-12.56%
|
$5,042,016
$84.77 P/Share
|
|
Jan 30
2023
|
Maria E Pasquale EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
60,024
+11.04%
|
$4,441,776
$74.19 P/Share
|
|
Jan 26
2023
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,419
-4.34%
|
$205,615
$85.0 P/Share
|
|
Jan 26
2023
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Open market or private sale
|
Direct |
7,000
-14.05%
|
$595,000
$85.0 P/Share
|
|
Jan 26
2023
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+12.32%
|
$476,000
$68.62 P/Share
|
|
Jan 20
2023
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+8.21%
|
-
|
|
Jan 20
2023
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
BUY
Grant, award, or other acquisition
|
Direct |
6,159
+14.49%
|
-
|
|
Jan 20
2023
|
Michael James Morrissey EVP, Head of Tech. Operations |
BUY
Grant, award, or other acquisition
|
Direct |
6,159
+9.12%
|
-
|
|
Jan 20
2023
|
Paula J Swain EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+5.55%
|
-
|
|
Jan 20
2023
|
Herve Hoppenot Chairman / CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,196
+6.29%
|
-
|
|
Jan 20
2023
|
Barry P Flannelly EVP & General Manager US |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+6.03%
|
-
|
|
Jan 20
2023
|
Maria E Pasquale EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+6.78%
|
-
|
|
Jan 20
2023
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+6.03%
|
-
|
|
Jan 20
2023
|
Thomas Tray Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,833
+12.72%
|
-
|
|
Jan 20
2023
|
Steven H Stein EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+4.19%
|
-
|
|
Jan 20
2023
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+10.42%
|
-
|
|
Jan 19
2023
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
105
-0.19%
|
$8,715
$83.88 P/Share
|
|
Jan 19
2023
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
105
-0.35%
|
$8,715
$83.88 P/Share
|
|
Jan 17
2023
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
87
-0.16%
|
$7,047
$81.26 P/Share
|
|
Jan 17
2023
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
87
-0.29%
|
$7,047
$81.26 P/Share
|
|
Jan 15
2023
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
87
-0.16%
|
$7,047
$81.26 P/Share
|
|
Jan 15
2023
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
87
-0.29%
|
$7,047
$81.26 P/Share
|
|
Jan 04
2023
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
117
-0.38%
|
$9,243
$79.08 P/Share
|
|
Jan 04
2023
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,399
-20.67%
|
$2,243,521
$79.78 P/Share
|
|
Jan 04
2023
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
117
-0.21%
|
$9,243
$79.08 P/Share
|